MarketPulse

cash position

28 articles
Investing.comInvesting.com··Nathan Reiff

IonQ's Blowout Earnings Widen Gap With Struggling Rival D-Wave

IonQ surges ahead with $62M revenue (429% YoY growth, 55% above guidance) and $3.3B cash versus D-Wave's $900M position, widening competitive advantage.
QBTSIONQIONQ.WSquantum computingcash position
The Motley FoolThe Motley Fool··Matt Dilallo

Berkshire's $381.7B War Chest and AI Immunity Position It as Safe Harbor

Berkshire Hathaway's record $381.7B cash position and AI-resilient portfolio under new CEO Greg Abel position it as defensive alternative amid market uncertainty.
AMZNGOOGGOOGLAAPLBRK.A+5cash positionAI disruption
Investing.comInvesting.com··Nathan Reiff

D-Wave Eyes Growth Trajectory Despite Q4 Earnings Shortfall

D-Wave missed Q4 earnings estimates but showed strong full-year 179% revenue growth and record bookings, signaling momentum despite quarterly shortfall.
QBTSacquisitionearnings miss
BenzingaBenzinga··Stjepan Kalinic

SoundHound AI Posts Record Q4 Results, Projects 33-54% Revenue Growth in 2026

SoundHound AI beat Q4 expectations with $55.1M revenue, up 59% YoY. Company projects 33-54% growth for 2026 amid strong voice AI demand.
SOUNSOUNWcash positionrevenue growth
The Motley FoolThe Motley Fool··Adam Spatacco

Thiel Macro Exits Major Tech Holdings, Moves to Cash Position

Thiel Macro liquidated entire tech portfolio including Nvidia, Tesla, Microsoft, and Apple, moving to cash amid AI competition, macro uncertainty, and geopolitical tensions.
NVDAMETAMSFTAMZNGOOG+4cash positionAI stocks
The Motley FoolThe Motley Fool··Adam Spatacco

Midterm Election Years Show Pattern of Market Volatility; 2026 Faces Historical Headwinds

S&P 500 historically drops 17.5% during midterm election years. 2026 faces similar volatility risk, though post-election rebounds average 15.4%.
FDSmarket volatilitycash position
GlobeNewswire Inc.GlobeNewswire Inc.··Inventiva

Inventiva Reports €99.3M Cash Position Following $172.5M Capital Raise

Inventiva raises $172.5M, boosting cash position to €99.3M and extending runway through mid-2027 to fund MASH therapy development.
IVAcash positionfinancing
BenzingaBenzinga··Prnewswire

Citius Oncology Posts Maiden Revenue of $3.9M From LYMPHIR Launch

Citius Oncology reports maiden revenue of $3.9M from LYMPHIR immunotherapy launch in December 2025, marking transition to commercial-stage biopharmaceutical company.
CTXRCTORnet lossFDA approval